Key points:

• The session focused on the proposed revisions to the European pharmaceutical legislation, highlighting two innovative regulatory instruments: the regulatory sandbox and platform technologies
• The regulatory sandbox is conceived as a supervised environment where stakeholders can collaboratively test and develop novel, high-impact innovations that are still in the early stages of development. It enables the exploration of adapted regulatory approaches to facilitate the effective development and authorisation of such products

To read more key points and the session summary, login as a member or register for free using the links below.